Breaking News

Saturday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Bristol stock too cheap, could be ready to rally, Barron's says » 09:35
12/04/21
12/04
09:35
12/04/21
09:35
BMY

Bristol-Myers

$56.30 /

+0.89 (+1.61%)

A healthcare crisis…

A healthcare crisis should have been good for biopharma stocks. Instead, it's been anything but. That may be about to change, Ben Levisohn writes in this week's edition of Barron's. Few pharma companies have been hit as hard as Bristol-Myers, with the stock dropping 11% so far this year amid concerns that it will lose exclusivity on drugs like multiple-myeloma treatment Revlimid in 2022, and cancer treatment Opdivo and blood-clot preventer Eliquis later this decade, the authors notes. But if pharma is cheap, then Bristol, at just seven times 2022 earnings, looks like a bargain-especially if those concerns are overblown, he contends. Reference Link

ShowHide Related Items >><<
BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

Friday
Options
Unusually active option classes on open December 3rd » 09:40
12/03/21
12/03
09:40
12/03/21
09:40
APSG

Apollo Strategic Growth Capital

$9.83 /

+ (+0.00%)

, SU

Suncor

$24.16 /

+ (+0.00%)

, BIG

Big Lots

$43.62 /

+ (+0.00%)

, UCO

Universal Compression

$69.89 /

-0.08 (-0.11%)

, ARDX

Ardelyx

$1.70 /

+ (+0.00%)

, USO

United States Oil Fund

$48.30 /

+ (+0.00%)

, UPST

Upstart

$176.65 /

-0.06 (-0.03%)

, DNA

Ginkgo Bioworks

$10.21 /

+ (+0.00%)

, JD

JD.com

$84.49 /

+ (+0.00%)

, AUPH

Aurinia Pharmaceuticals

$20.16 /

+0.02 (+0.10%)

Unusual total active…

Unusual total active option classes on open include: Apollo Strategic Growth Capital (APSG), Suncor (SU), Big Lots (BIG), ProShares Ultra DJ UBS Crude Oil (UCO), Ardelyx (ARDX), United States Oil Fund (USO), Upstart Holdings (UPST), Ginkgo Bioworks (DNA), JD.com (JD), and Aurinia Pharmaceuticals (AUPH).

ShowHide Related Items >><<
UPST Upstart
$176.65 /

-0.06 (-0.03%)

UCO Universal Compression
$69.89 /

-0.08 (-0.11%)

SU Suncor
$24.16 /

+ (+0.00%)

JD JD.com
$84.49 /

+ (+0.00%)

DNA Ginkgo Bioworks
$10.21 /

+ (+0.00%)

BIG Big Lots
$43.62 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$20.16 /

+0.02 (+0.10%)

ARDX Ardelyx
$1.70 /

+ (+0.00%)

APSG Apollo Strategic Growth Capital
$9.83 /

+ (+0.00%)

SU Suncor
$24.16 /

+ (+0.00%)

11/19/21 Scotiabank
Suncor price target raised to C$37 from C$33 at Scotiabank
11/02/21 Credit Suisse
Suncor price target raised to C$42 from C$36 at Credit Suisse
10/29/21 BMO Capital
Suncor price target raised to C$43 from C$39 at BMO Capital
10/28/21 JPMorgan
Suncor upgraded to Overweight from Neutral at JPMorgan
BIG Big Lots
$43.62 /

+ (+0.00%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
UCO Universal Compression
$69.89 /

-0.08 (-0.11%)

ARDX Ardelyx
$1.70 /

+ (+0.00%)

12/01/21 Ladenburg
Ardelyx upgraded to Buy at Ladenburg on IBS-C treatment launch plan
12/01/21 Ladenburg
Ardelyx upgraded to Buy from Neutral at Ladenburg
12/01/21 Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Citi
Ardelyx price target raised to $13 from $7 at Citi
USO United States Oil Fund
$48.30 /

+ (+0.00%)

UPST Upstart
$176.65 /

-0.06 (-0.03%)

12/03/21 Citi
Citi upgrades Upstart to Buy on resumption after 55% selloff
12/03/21 Citi
Upstart upgraded to Buy from Neutral at Citi
11/10/21 Piper Sandler
Upstart should be bought on earnings selloff, says Piper Sandler
10/26/21
Fly Intel: Top five analyst downgrades
DNA Ginkgo Bioworks
$10.21 /

+ (+0.00%)

11/29/21 Jefferies
Ginkgo Bioworks initiated with a Buy at Jefferies
10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
JD JD.com
$84.49 /

+ (+0.00%)

11/19/21 Benchmark
JD.com price target raised to $117 from $102 at Benchmark
11/19/21 UBS
JD.com price target raised to $110 from $95 at UBS
11/19/21 Mizuho
JD.com price target raised to $100 from $95 at Mizuho
11/19/21 Citi
JD.com price target raised to $115 from $108 at Citi
AUPH Aurinia Pharmaceuticals
$20.16 /

+0.02 (+0.10%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
UPST Upstart
$176.65 /

-0.06 (-0.03%)

SU Suncor
$24.16 /

+ (+0.00%)

JD JD.com
$84.49 /

+ (+0.00%)

DNA Ginkgo Bioworks
$10.21 /

+ (+0.00%)

BIG Big Lots
$43.62 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$20.16 /

+0.02 (+0.10%)

ARDX Ardelyx
$1.70 /

+ (+0.00%)

  • 16
    Jun
  • 09
    Apr
  • 16
    Dec
USO United States Oil Fund
$48.30 /

+ (+0.00%)

JD JD.com
$84.49 /

+ (+0.00%)

DNA Ginkgo Bioworks
$10.21 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$20.16 /

+0.02 (+0.10%)

UPST Upstart
$176.65 /

-0.06 (-0.03%)

JD JD.com
$84.49 /

+ (+0.00%)

DNA Ginkgo Bioworks
$10.21 /

+ (+0.00%)

BIG Big Lots
$43.62 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$20.16 /

+0.02 (+0.10%)

ARDX Ardelyx
$1.70 /

+ (+0.00%)

USO United States Oil Fund
$48.30 /

+ (+0.00%)

UPST Upstart
$176.65 /

-0.06 (-0.03%)

UCO Universal Compression
$69.89 /

-0.08 (-0.11%)

SU Suncor
$24.16 /

+ (+0.00%)

JD JD.com
$84.49 /

+ (+0.00%)

DNA Ginkgo Bioworks
$10.21 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$20.16 /

+0.02 (+0.10%)

ARDX Ardelyx
$1.70 /

+ (+0.00%)

APSG Apollo Strategic Growth Capital
$9.83 /

+ (+0.00%)

Hot Stocks
Bristol-Myers: FDA accepts for priority review sBLA for Reblozyl » 07:00
12/03/21
12/03
07:00
12/03/21
07:00
BMY

Bristol-Myers

$55.41 /

+0.46 (+0.84%)

, MRK

Merck

$73.89 /

-0.54 (-0.73%)

Bristol Myers Squibb…

Bristol Myers Squibb (BMY) announced that the U.S. FDA has accepted for priority review the supplemental Biologics License Application for Reblozyl, a first-in-class erythroid maturation agent, for the treatment of anemia in adults with non-transfusion dependent beta thalassemia. The FDA has set a Prescription Drug User Fee Act goal date of March 27, 2022. In addition, the European Medicines Agency has validated the Type II variation for Reblozyl in NTD beta thalassemia. Reblozyl is being co-developed and co-commercialized with Merck & Co. (MRK) following Merck's recent acquisition of Acceleron Pharma. These applications were based on safety and efficacy results from the pivotal Phase 2 BEYOND study evaluating Reblozyl plus best supportive care in patients with NTD beta thalassemia.

ShowHide Related Items >><<
MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
MRK Merck
$73.89 /

-0.54 (-0.73%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

Over a week ago
Hot Stocks
FDA accepts Bristol-Myers' NDA for deucravacitinib in severe plaque psoriasis » 07:01
11/29/21
11/29
07:01
11/29/21
07:01
BMY

Bristol-Myers

$56.30 /

-0.51 (-0.90%)

The company states:…

The company states: "Bristol Myers announced that the FDA has accepted the New Drug Application and the European Medicines Agency has validated the Marketing Authorization Application for deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis. The FDA has assigned a Prescription Drug User Fee Act, or PDUFA, goal date of September 10, 2022. These latest regulatory milestones are in addition to the NDA acceptance by Japan's Ministry of Health, Labour and Welfare for deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis, pustular psoriasis and erythrodermic psoriasis. The regulatory applications are based on positive results from the pivotal POETYK PSO-1 and POETYK PSO-2 trials, which evaluated once daily deucravacitinib in patients with moderate to severe plaque psoriasis versus placebo and Otezla. Deucravacitinib demonstrated significant and clinically meaningful improvements in skin clearance, symptom burden and quality of life measures compared to placebo and Otezla. Deucravacitinib was well-tolerated with a low rate of discontinuation due to adverse events, with no clinically meaningful lab abnormalities. Primary results were presented at the American Academy of Dermatology Virtual Meeting Experience in April 2021, and additional analyses were presented at the European Academy of Dermatology and Venereology 30th Anniversary Congress in September 2021."

ShowHide Related Items >><<
BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

Upgrade
Societe Generale upgrades AbbVie to Buy on better than anticipated execution » 07:47
11/23/21
11/23
07:47
11/23/21
07:47
ABBV

AbbVie

$115.68 /

-0.56 (-0.48%)

, BMY

Bristol-Myers

$57.04 /

-0.79 (-1.37%)

Societe Generale analyst…

Societe Generale analyst Justin Smith upgraded AbbVie (ABBV) to Buy from Hold with a price target of $172, up from $111, telling investors that he sees management executing better than he anticipated on two franchises "crucial to its long-term prospects," immuno-inflammation and aesthetics. AbbVie is replacing Bristol Myers Squibb (BMY) as his preferred value call in global large cap pharma given its improved "long-term replacement power," added Smith, who now has "full conviction" in management's long-term guidance for Allergan's aesthetics franchise following the company's Q3 report.

ShowHide Related Items >><<
BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

ABBV AbbVie
$115.68 /

-0.56 (-0.48%)

ABBV AbbVie
$115.68 /

-0.56 (-0.48%)

11/23/21 Societe Generale
AbbVie upgraded to Buy from Hold at Societe Generale
11/18/21 Piper Sandler
Vertex downgraded to Neutral at Piper ahead of AbbVie CF data
11/17/21 Truist
AbbVie triple data could be pushed back, says Truist
11/01/21 Morgan Stanley
AbbVie price target raised to $124 from $116 at Morgan Stanley
BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
11/08/21 Wedbush
Wedbush bullish on 2seventy Bio, initiates with an Outperform
BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

ABBV AbbVie
$115.68 /

-0.56 (-0.48%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

ABBV AbbVie
$115.68 /

-0.56 (-0.48%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

ABBV AbbVie
$115.68 /

-0.56 (-0.48%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

ABBV AbbVie
$115.68 /

-0.56 (-0.48%)

Hot Stocks
Bristol-Myers announces Market Authorization in Europe for Zeposia » 07:01
11/23/21
11/23
07:01
11/23/21
07:01
BMY

Bristol-Myers

$57.04 /

-0.79 (-1.37%)

Bristol Myers Squibb…

Bristol Myers Squibb announced the European Commission has granted a Marketing Authorization for Zeposia, or ozanimod, for the treatment of adults with moderately to severely active ulcerative colitis, or UC, who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent. Zeposia, an oral medication taken once daily, is a sphingosine 1-phosphate, or S1P, receptor modulator that binds with high affinity selectively to S1P subtypes 1 and 5. Zeposia is the first and only oral S1P receptor modulator approved for UC, and represents a new way of treating this chronic immune-mediated disease.

ShowHide Related Items >><<
BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
11/08/21 Wedbush
Wedbush bullish on 2seventy Bio, initiates with an Outperform
BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

BMY Bristol-Myers
$57.04 /

-0.79 (-1.37%)

On The Fly
Wall Street in Fives - Must Read Lists for Monday » 16:25
11/22/21
11/22
16:25
11/22/21
16:25
ERIC

Ericsson

$10.13 /

-0.795 (-7.28%)

, VG

Vonage

$20.81 /

+4.44 (+27.12%)

, AVYA

Avaya

$22.00 /

+4.02 (+22.36%)

, TSLA

Tesla

$1,156.86 /

+20.35 (+1.79%)

, WMT

Walmart

$144.77 /

+2.37 (+1.66%)

, TWTR

Twitter

$47.31 /

-1.13 (-2.33%)

, ATVI

Activision Blizzard

$62.20 /

-0.17 (-0.27%)

, GFS

GlobalFoundries

$63.83 /

+1.93 (+3.12%)

, BLNK

Blink Charging

$38.20 /

-4.895 (-11.36%)

, TDOC

Teladoc

$109.10 /

-7.79 (-6.66%)

, XEL

Xcel Energy

$66.29 /

+1.18 (+1.81%)

, MNST

Monster Beverage

$90.09 /

+0.79 (+0.88%)

, AAPL

Apple

$161.12 /

+0.57 (+0.36%)

, MVRS

Meta

/

+

, FB

Facebook; also tag MVRS

$341.17 /

-4.19 (-1.21%)

, BA

Boeing

$209.91 /

-4.11 (-1.92%)

, ASTR

Astra

$11.15 /

+1.625 (+17.06%)

, PRVB

Provention Bio

$7.18 /

+0.925 (+14.80%)

, XPEV

XPeng

$47.40 /

+0.54 (+1.15%)

, RIVN

Rivian Automotive

$118.73 /

-9.91 (-7.70%)

, F

Ford

$20.48 /

+1.09 (+5.62%)

, AUPH

Aurinia Pharmaceuticals

$19.65 /

-8.84 (-31.03%)

, CRNC

Cerence

$82.50 /

-21.42 (-20.61%)

, ELYS

Elys Game Technology

$3.32 /

-0.49 (-12.86%)

, QIPT

Quipt Home Medical

$6.77 /

-0.075 (-1.10%)

, FNA

Paragon 28

$20.59 /

-0.53 (-2.51%)

, TWST

Twist Bioscience

$98.22 /

-12.615 (-11.38%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

XEL Xcel Energy
$66.29 /

+1.18 (+1.81%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

MVRS Meta
/

+

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

GFS GlobalFoundries
$63.83 /

+1.93 (+3.12%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

F Ford
$20.48 /

+1.09 (+5.62%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

CRNC Cerence
$82.50 /

-21.42 (-20.61%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AVYA Avaya
$22.00 /

+4.02 (+22.36%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

ASTR Astra
$11.15 /

+1.625 (+17.06%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

11/23/21 KeyBanc
Vonage downgraded to Sector Weight from Overweight at KeyBanc
10/25/21 BofA
Ericsson reinstated with an Underperform at BofA
10/20/21 JPMorgan
Ericsson price target lowered to SEK 123 from SEK 125 at JPMorgan
10/20/21 Cowen
Ericsson price target lowered to $18 from $21 at Cowen
VG Vonage
$20.81 /

+4.44 (+27.12%)

11/23/21 Baird
Vonage downgraded to Neutral from Outperform at Baird
11/22/21 Craig-Hallum
Vonage downgraded to Hold from Buy at Craig-Hallum
11/22/21 Jefferies
Jefferies raises Vonage price target to $21, sees high odds acquisition closes
AVYA Avaya
$22.00 /

+4.02 (+22.36%)

11/23/21 Citi
Avaya price target raised to $25 from $24 at Citi
11/12/21 Cowen
Avaya price target lowered to $33 from $40 at Cowen
10/20/21 Barclays
Avaya downgraded to Equal Weight from Overweight at Barclays
10/18/21 JPMorgan
Avaya downgraded to Neutral into 'more modest year' at JPMorgan
TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
11/15/21 Wedbush
GM stock may hit $100 over next 12-18 months in bull case scenario, says Wedbush
WMT Walmart
$144.77 /

+2.37 (+1.66%)

11/19/21
Fly Intel: Top five analyst upgrades
11/19/21 MKM Partners
MKM upgrades Walmart to Buy with $166 target heading into holidays
11/19/21 MKM Partners
Walmart upgraded to Buy from Neutral at MKM Partners
11/18/21 Credit Suisse
Credit Suisse transfers coverage of Walmart
TWTR Twitter
$47.31 /

-1.13 (-2.33%)

11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/01/21 Citi
Citi upgrades Snap to Neutral, cuts price target to $53
10/28/21 BMO Capital
Twitter price target lowered to $65 from $70 at BMO Capital
10/28/21 Wells Fargo
Twitter price target lowered to $70 from $82 at Wells Fargo
ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

11/22/21
Fly Intel: Top five analyst downgrades
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
11/22/21 Truist
Activision Blizzard price target lowered to $74 from $101 at Truist
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
GFS GlobalFoundries
$63.83 /

+1.93 (+3.12%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

11/22/21 Cowen
Blink Charging downgraded to Market Perform from Outperform at Cowen
11/15/21
Fly Intel: Top five analyst upgrades
11/15/21 DA Davidson
Blink Charging price target raised to $35 from $31 at DA Davidson
TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

11/23/21 Canaccord
Teladoc price target lowered to $160 from $188 at Canaccord
11/22/21 Stifel
Teladoc price target lowered to $135 from $153 at Stifel
11/22/21 BTIG
Teladoc downgraded to Neutral from Buy at BTIG
XEL Xcel Energy
$66.29 /

+1.18 (+1.81%)

11/22/21
Fly Intel: Top five analyst upgrades
11/21/21 BMO Capital
Xcel Energy upgraded to Outperform from Market Perform at BMO Capital
11/02/21 Mizuho
Xcel Energy price target lowered to $64 from $70 at Mizuho
10/29/21 BofA
Xcel Energy upgraded to Buy at BofA following underperformance
MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

11/23/21 Morgan Stanley
Full Monster-Constellation combo 'less plausible' than JV, says Morgan Stanley
11/23/21 Citi
Citi 'highly skeptical' Coke would abandon relationship with Monster
11/22/21 Stifel
Monster-Constellation JV makes sense, merger 'less so,' says Stifel
11/02/21 Deutsche Bank
Monster Beverage price target lowered to $105 from $108 at Deutsche Bank
AAPL Apple
$161.12 /

+0.57 (+0.36%)

11/23/21 Credit Suisse
Matterport price target raised to $34 from $25 at Credit Suisse
11/19/21 Morgan Stanley
Morgan Stanley lays out five points to keep in mind on Apple Car
11/18/21 Piper Sandler
Jamf competitive threat from Apple is minimal, says Piper Sandler
MVRS Meta
/

+

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
BA Boeing
$209.91 /

-4.11 (-1.92%)

11/18/21
Fly Intel: Top five analyst upgrades
11/18/21 JPMorgan
Boeing upgraded to Overweight from Neutral at JPMorgan
11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 Wells Fargo
Wells Fargo upgrades Boeing on positive risk/reward after underperformance
ASTR Astra
$11.15 /

+1.625 (+17.06%)

10/11/21 Deutsche Bank
Astra named short-term investment idea at Deutsche Bank
10/04/21
Fly Intel: Top five analyst initiations
10/04/21 BofA
Astra initiated with an Underperform at BofA
07/27/21 Deutsche Bank
Astra initiated with a Buy at Deutsche Bank
PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

11/23/21 SMBC Nikko
Provention Bio upgraded to Outperform from Neutral at SMBC Nikko
07/09/21 Chardan
Provention Bio coverage transferred at Chardan
05/28/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
05/25/21 SVB Leerink
Provention Bio briefing documents a positive, says SVB Leerink
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
10/28/21 Bernstein
Bernstein starts XPeng at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
XPeng initiated with an Outperform at Bernstein
RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

F Ford
$20.48 /

+1.09 (+5.62%)

11/11/21 Morgan Stanley
Morgan Stanley bumps up Ford price target to $12, stays Underweight
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
11/02/21 Nomura
Ford downgraded to Reduce from Neutral at Nomura
10/29/21 Tigress Financial
Snap-On price target raised to $295 from $289 at Tigress Financial
AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
CRNC Cerence
$82.50 /

-21.42 (-20.61%)

11/23/21 Craig-Hallum
Cerence price target lowered to $135 from $145 at Craig-Hallum
11/23/21 Wedbush
Cerence price target lowered to $115 from $140 at Wedbush
11/23/21 RBC Capital
Cerence price target lowered to $95 from $110 at RBC Capital
10/06/21 RBC Capital
RBC Capital upgraded Cerence to Outperform, sees selloff as overdone
ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

07/26/21 Maxim
Elys Game Technology initiated with a Buy at Maxim
03/10/21
Fly Intel: Top five analyst initiations
03/10/21 H.C. Wainwright
Elys Game Technology initiated with a Buy at H.C. Wainwright
QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

11/19/21 Canaccord
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord
11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
FNA Paragon 28
$20.59 /

-0.53 (-2.51%)

11/22/21 Piper Sandler
Paragon 28 a 'name to own' after strong first public report, says Piper Sandler
11/09/21 Canaccord
Canaccord starts foot & ankle share taker Paragon 28 with a Buy
11/09/21 Needham
Paragon 28 initiated with a Buy at Needham
11/09/21 Canaccord
Paragon 28 initiated with a Buy at Canaccord
TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

11/23/21 Baird
Twist Bioscience price target lowered to $113 from $130 at Baird
10/14/21 Cowen
Twist Bioscience coverage transferred at Cowen
08/09/21 Baird
Twist Bioscience price target lowered to $130 from $140 at Baird
06/29/21 William Blair
Twist Bioscience initiated with an Outperform at William Blair
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

XEL Xcel Energy
$66.29 /

+1.18 (+1.81%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

FNA Paragon 28
$20.59 /

-0.53 (-2.51%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

F Ford
$20.48 /

+1.09 (+5.62%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

CRNC Cerence
$82.50 /

-21.42 (-20.61%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AVYA Avaya
$22.00 /

+4.02 (+22.36%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

  • 10
    Nov
  • 28
    Oct
  • 15
    Oct
  • 14
    Jan
  • 08
    Jan
  • 09
    Dec
  • 03
    Dec
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

MVRS Meta
/

+

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

XPEV XPeng
$47.40 /

+0.54 (+1.15%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

GFS GlobalFoundries
$63.83 /

+1.93 (+3.12%)

FNA Paragon 28
$20.59 /

-0.53 (-2.51%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

CRNC Cerence
$82.50 /

-21.42 (-20.61%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

ASTR Astra
$11.15 /

+1.625 (+17.06%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

XPEV XPeng
$47.40 /

+0.54 (+1.15%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

F Ford
$20.48 /

+1.09 (+5.62%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AVYA Avaya
$22.00 /

+4.02 (+22.36%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

ASTR Astra
$11.15 /

+1.625 (+17.06%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:10
11/22/21
11/22
12:10
11/22/21
12:10
VG

Vonage

$20.62 /

+4.25 (+25.96%)

, ERIC

Ericsson

$10.23 /

-0.695 (-6.36%)

, AVYA

Avaya

$21.70 /

+3.72 (+20.69%)

, CRNC

Cerence

$82.95 /

-20.97 (-20.18%)

, TSLA

Tesla

$1,151.58 /

+15.07 (+1.33%)

, MNST

Monster Beverage

$90.25 /

+0.945 (+1.06%)

, STZ

Constellation Brands

$234.69 /

-0.68 (-0.29%)

, STZ.B

Constellation Brands; also tag STZ

$239.26 /

+24.95 (+11.64%)

, ATVI

Activision Blizzard

$60.69 /

-1.68 (-2.69%)

, AAPL

Apple

$163.63 /

+3.075 (+1.92%)

, NFLX

Netflix

$659.68 /

-18.915 (-2.79%)

, MVRS

Meta

/

+

, FB

Facebook; also tag MVRS

$341.07 /

-4.29 (-1.24%)

, ASTR

Astra

$12.11 /

+2.585 (+27.14%)

, PRVB

Provention Bio

$7.26 /

+1.01 (+16.16%)

, XPEV

XPeng

$47.50 /

+0.64 (+1.37%)

, RIVN

Rivian Automotive

$111.43 /

-17.21 (-13.38%)

, F

Ford

$19.90 /

+0.51 (+2.63%)

, AUPH

Aurinia Pharmaceuticals

$20.08 /

-8.41 (-29.52%)

, SR

Spire

$62.47 /

+0.82 (+1.33%)

, ELYS

Elys Game Technology

$3.37 /

-0.44 (-11.55%)

, QIPT

Quipt Home Medical

$6.87 /

+0.03 (+0.44%)

, FNA

Paragon 28

$21.90 /

+0.78 (+3.69%)

, TWST

Twist Bioscience

$100.90 /

-9.935 (-8.96%)

, GFS

GlobalFoundries

$65.00 /

+3.1 (+5.01%)

, BLNK

Blink Charging

$37.94 /

-5.15 (-11.95%)

, TDOC

Teladoc

$108.83 /

-8.06 (-6.90%)

, XEL

Xcel Energy

$66.87 /

+1.76 (+2.70%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

XEL Xcel Energy
$66.87 /

+1.76 (+2.70%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

SR Spire
$62.47 /

+0.82 (+1.33%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MVRS Meta
/

+

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

CRNC Cerence
$82.95 /

-20.97 (-20.18%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AVYA Avaya
$21.70 /

+3.72 (+20.69%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

ASTR Astra
$12.11 /

+2.585 (+27.14%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

11/22/21 William Blair
Vonage downgraded to Market Perform from Outperform at William Blair
11/22/21 Northland
Vonage downgraded to Market Perform from Outperform at Northland
11/22/21 Colliers
Vonage downgraded to Neutral from Buy at Colliers
11/05/21 JPMorgan
Vonage upgraded to Overweight from Neutral at JPMorgan
ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

10/25/21 BofA
Ericsson reinstated with an Underperform at BofA
10/20/21 JPMorgan
Ericsson price target lowered to SEK 123 from SEK 125 at JPMorgan
10/20/21 Cowen
Ericsson price target lowered to $18 from $21 at Cowen
10/08/21 Barclays
Ericsson price target raised to SEK 150 from SEK 145 at Barclays
AVYA Avaya
$21.70 /

+3.72 (+20.69%)

11/12/21 Cowen
Avaya price target lowered to $33 from $40 at Cowen
10/20/21 Barclays
Avaya downgraded to Equal Weight from Overweight at Barclays
10/18/21 JPMorgan
Avaya downgraded to Neutral into 'more modest year' at JPMorgan
10/18/21 JPMorgan
Avaya downgraded to Neutral from Overweight at JPMorgan
CRNC Cerence
$82.95 /

-20.97 (-20.18%)

10/06/21 RBC Capital
RBC Capital upgraded Cerence to Outperform, sees selloff as overdone
10/06/21 RBC Capital
Cerence upgraded to Outperform from Sector Perform at RBC Capital
08/16/21 Evercore ISI
Cerence price target raised to $150 from $125 at Evercore ISI
08/10/21 Baird
Cerence price target raised to $135 from $122 at Baird
TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
11/15/21 Wedbush
GM stock may hit $100 over next 12-18 months in bull case scenario, says Wedbush
MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

11/22/21 Stifel
Monster-Constellation JV makes sense, merger 'less so,' says Stifel
11/02/21 Deutsche Bank
Monster Beverage price target lowered to $105 from $108 at Deutsche Bank
11/01/21
Fly Intel: Top five analyst initiations
11/01/21 Redburn
Monster Beverage initiated with a Neutral at Redburn
STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

11/01/21 Cantor Fitzgerald
Tilray downgraded to Neutral from Overweight at Cantor Fitzgerald
10/13/21 HSBC
HSBC upgrades Constellation Brands to Buy on ' strong' fundamentals
10/13/21 HSBC
Constellation Brands upgraded to Buy from Hold at HSBC
STZ.B Constellation Brands; also tag STZ
$239.26 /

+24.95 (+11.64%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

11/22/21
Fly Intel: Top five analyst downgrades
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
11/22/21 Truist
Activision Blizzard price target lowered to $74 from $101 at Truist
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
AAPL Apple
$163.63 /

+3.075 (+1.92%)

11/19/21 Morgan Stanley
Morgan Stanley lays out five points to keep in mind on Apple Car
11/18/21 Piper Sandler
Jamf competitive threat from Apple is minimal, says Piper Sandler
11/17/21 Bernstein
Apple able to repurchase 3%-4% of shares/year until end of 2026, says Bernstein
NFLX Netflix
$659.68 /

-18.915 (-2.79%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/15/21 KeyBanc
Netflix price target raised to $725 from $690 at KeyBanc
11/15/21 JPMorgan
Netflix entering 'strongest content quarter ever,' says JPMorgan
MVRS Meta
/

+

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
ASTR Astra
$12.11 /

+2.585 (+27.14%)

10/11/21 Deutsche Bank
Astra named short-term investment idea at Deutsche Bank
10/04/21
Fly Intel: Top five analyst initiations
10/04/21 BofA
Astra initiated with an Underperform at BofA
07/27/21 Deutsche Bank
Astra initiated with a Buy at Deutsche Bank
PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

07/09/21 Chardan
Provention Bio coverage transferred at Chardan
05/28/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
05/25/21 SVB Leerink
Provention Bio briefing documents a positive, says SVB Leerink
05/07/21 Cantor Fitzgerald
Provention Bio price target lowered to $19 from $25 at Cantor Fitzgerald
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
10/28/21 Bernstein
Bernstein starts XPeng at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
XPeng initiated with an Outperform at Bernstein
RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

F Ford
$19.90 /

+0.51 (+2.63%)

11/11/21 Morgan Stanley
Morgan Stanley bumps up Ford price target to $12, stays Underweight
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
11/02/21 Nomura
Ford downgraded to Reduce from Neutral at Nomura
10/29/21 Tigress Financial
Snap-On price target raised to $295 from $289 at Tigress Financial
AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
SR Spire
$62.47 /

+0.82 (+1.33%)

11/19/21 Mizuho
Spire price target lowered to $69 from $73 at Mizuho
11/16/21 JPMorgan
Spire downgraded to Neutral from Overweight at JPMorgan
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 BofA
Spire downgraded to Neutral from Buy at BofA
ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

07/26/21 Maxim
Elys Game Technology initiated with a Buy at Maxim
03/10/21
Fly Intel: Top five analyst initiations
03/10/21 H.C. Wainwright
Elys Game Technology initiated with a Buy at H.C. Wainwright
QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

11/19/21 Canaccord
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord
11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
FNA Paragon 28
$21.90 /

+0.78 (+3.69%)

11/09/21 Canaccord
Canaccord starts foot & ankle share taker Paragon 28 with a Buy
11/09/21 Needham
Paragon 28 initiated with a Buy at Needham
11/09/21 Canaccord
Paragon 28 initiated with a Buy at Canaccord
11/09/21 JMP Securities
Paragon 28 initiated with an Outperform at JMP Securities
TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

10/14/21 Cowen
Twist Bioscience coverage transferred at Cowen
08/09/21 Baird
Twist Bioscience price target lowered to $130 from $140 at Baird
06/29/21 William Blair
Twist Bioscience initiated with an Outperform at William Blair
06/04/21
Fly Intel: Top five analyst initiations
GFS GlobalFoundries
$65.00 /

+3.1 (+5.01%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

11/22/21 Cowen
Blink Charging downgraded to Market Perform from Outperform at Cowen
11/15/21
Fly Intel: Top five analyst upgrades
11/15/21 DA Davidson
Blink Charging price target raised to $35 from $31 at DA Davidson
TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

11/22/21 Stifel
Teladoc price target lowered to $135 from $153 at Stifel
11/22/21 BTIG
Teladoc downgraded to Neutral from Buy at BTIG
11/22/21 BTIG
Teladoc downgraded to Neutral from Buy at BTIG
XEL Xcel Energy
$66.87 /

+1.76 (+2.70%)

11/22/21
Fly Intel: Top five analyst upgrades
11/21/21 BMO Capital
Xcel Energy upgraded to Outperform from Market Perform at BMO Capital
11/02/21 Mizuho
Xcel Energy price target lowered to $64 from $70 at Mizuho
10/29/21 BofA
Xcel Energy upgraded to Buy at BofA following underperformance
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

XEL Xcel Energy
$66.87 /

+1.76 (+2.70%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ.B Constellation Brands; also tag STZ
$239.26 /

+24.95 (+11.64%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

SR Spire
$62.47 /

+0.82 (+1.33%)

QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

FNA Paragon 28
$21.90 /

+0.78 (+3.69%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

CRNC Cerence
$82.95 /

-20.97 (-20.18%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AVYA Avaya
$21.70 /

+3.72 (+20.69%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

  • 10
    Nov
  • 28
    Oct
  • 15
    Oct
  • 14
    Jan
  • 08
    Jan
  • 09
    Dec
  • 03
    Dec
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MVRS Meta
/

+

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

XPEV XPeng
$47.50 /

+0.64 (+1.37%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ.B Constellation Brands; also tag STZ
$239.26 /

+24.95 (+11.64%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MVRS Meta
/

+

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

GFS GlobalFoundries
$65.00 /

+3.1 (+5.01%)

FNA Paragon 28
$21.90 /

+0.78 (+3.69%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

CRNC Cerence
$82.95 /

-20.97 (-20.18%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

ASTR Astra
$12.11 /

+2.585 (+27.14%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

XPEV XPeng
$47.50 /

+0.64 (+1.37%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AVYA Avaya
$21.70 /

+3.72 (+20.69%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

ASTR Astra
$12.11 /

+2.585 (+27.14%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

Hot Stocks
Aurinia sinks with buyout speculation seen as 'past its expiration' » 09:42
11/22/21
11/22
09:42
11/22/21
09:42
AUPH

Aurinia Pharmaceuticals

$28.49 /

+ (+0.00%)

Shares of Aurinia…

Shares of Aurinia Pharmaceuticals are falling after the company late Friday filed a prospectus agreement to sell shares. Aurinia also entered a sales agreement, which covers the offering, issuance and sale of up to a maximum aggregate offering price of $250M of common shares that may be issued and sold from time to time under a controlled equity offering sales agreement with Cantor Fitzgerald. Following the news, STAT's Adam Feuerstein tweeted that Aurinia's "buyout speculation looks well past its expiration date." Aurinia Pharmaceuticals shares are down 18% to $23.25 in early trading.

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$28.49 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$28.49 /

+ (+0.00%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
AUPH Aurinia Pharmaceuticals
$28.49 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$28.49 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$28.49 /

+ (+0.00%)

AUPH Aurinia Pharmaceuticals
$28.49 /

+ (+0.00%)

Syndicate
Aurinia enters sales agreement prospectus with Cantor for $250M of shares » 09:39
11/22/21
11/22
09:39
11/22/21
09:39
AUPH

Aurinia Pharmaceuticals

$28.49 /

-1.14 (-3.85%)

Aurinia Pharmaceuticals…

Aurinia Pharmaceuticals on Friday filed a registration that contains a base prospectus, which covers the offering, issuance and sale securities identified "from time to time." Aurinia also entered a sales agreement prospectus, which covers the offering, issuance and sale of up to a maximum aggregate offering price of $250M of common shares that may be issued and sold from time to time under a controlled equity offering sales agreement with Cantor Fitzgerald.

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$28.49 /

-1.14 (-3.85%)

AUPH Aurinia Pharmaceuticals
$28.49 /

-1.14 (-3.85%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
AUPH Aurinia Pharmaceuticals
$28.49 /

-1.14 (-3.85%)

AUPH Aurinia Pharmaceuticals
$28.49 /

-1.14 (-3.85%)

AUPH Aurinia Pharmaceuticals
$28.49 /

-1.14 (-3.85%)

AUPH Aurinia Pharmaceuticals
$28.49 /

-1.14 (-3.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.